COVID-19: Singapore approves first bivalent vaccine

Singapore has approved its first bivalent COVID-19 vaccine that targets both the original virus strain and the Omicron variant. It is an updated version of the Moderna shot and the company says it is able to bring in “hundreds of thousands” of doses into Singapore by the end of the month.

Subscribe to our channel here:

Subscribe to our news service on Telegram:

Follow us:
CNA Lifestyle:

You May Also Like